Clinical Case Reports (Oct 2021)
Colesevelam‐induced hypoglycaemia in a patient with type 1 diabetes mellitus
Abstract
Abstract Colesevelam possesses antidiabetic properties, which could potentiate sulphonylurea or insulin‐induced hypoglycemia; clinically significant hypoglycemia, as a side effect to bile acid sequestrants, may be under‐recognized in clinical practice.
Keywords